Drug Shortage Report for TEVA-LEVOCARBIDOPA
Report ID | 106945 |
Drug Identification Number | 02244496 |
Brand name | TEVA-LEVOCARBIDOPA |
Common or Proper name | LEVOCARBIDOPA 250MG/25MG TAB |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | CARBIDOPA LEVODOPA |
Strength(s) | 25MG 250MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | N04BA |
ATC description | DOPAMINERGIC AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-02-20 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2020-03-26 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2020-03-26 | French | Compare |
v3 | 2020-03-26 | English | Compare |
v2 | 2020-02-21 | French | Compare |
v1 | 2020-02-21 | English | Compare |
Showing 1 to 4 of 4